INVEX Therapeutics Ltd (IXC) — Financial Flexibility Index
INVEX Therapeutics Ltd (IXC) has a Financial Flexibility Index of -4.42x as of December 2025. Free cash flow of AU$-779.73K (operating CF AU$-779.73K minus capex AU$0.00) represents -4% of total liabilities (AU$176.49K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
INVEX Therapeutics Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for INVEX Therapeutics Ltd across 7 annual periods. See working capital position of INVEX Therapeutics Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for INVEX Therapeutics Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for INVEX Therapeutics Ltd. For the full company profile including market capitalisation, see INVEX Therapeutics Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.96x | AU$-652.57K | AU$-652.57K | AU$220.59K | ▲ +47.8% |
| 2024 | -5.66x | AU$-2.44 Million | AU$-2.44 Million | AU$431.63K | ▼ -29.6% |
| 2023 | -4.37x | AU$-6.87 Million | AU$-6.87 Million | AU$1.57 Million | ▼ -29.9% |
| 2022 | -3.36x | AU$-3.38 Million | AU$-3.38 Million | AU$1.00 Million | ▼ -32.0% |
| 2021 | -2.55x | AU$-1.68 Million | AU$-1.68 Million | AU$658.61K | ▼ -220.3% |
| 2020 | -0.80x | AU$-1.60 Million | AU$-1.60 Million | AU$2.02 Million | ▼ -235.3% |
| 2019 | -0.24x | AU$-221.94K | AU$-230.13K | AU$935.49K | — |